{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:45:31Z","timestamp":1784594731732,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI106734"],"award-info":[{"award-number":["AI106734"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000010","name":"Ford Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1090-3","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T12:40:24Z","timestamp":1453725624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax"],"prefix":"10.1186","volume":"15","author":[{"given":"C. Brandon","family":"Ogbunugafor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"issue":"Suppl 2","key":"1090_CR1","doi-asserted-by":"publisher","first-page":"10871","DOI":"10.1073\/pnas.1100299108","volume":"108","author":"AF Read","year":"2011","unstructured":"Read AF, Day T, Huijben S. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci USA. 2011;108(Suppl 2):10871\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1090_CR2","doi-asserted-by":"publisher","first-page":"e1003578","DOI":"10.1371\/journal.ppat.1003578","volume":"9","author":"S Huijben","year":"2013","unstructured":"Huijben S, Bell AS, Sim DG, Tomasello D, Mideo N, Day T, et al. Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathog. 2013;9:e1003578.","journal-title":"PLoS Pathog"},{"key":"1090_CR3","doi-asserted-by":"publisher","first-page":"20140566","DOI":"10.1098\/rspb.2014.0566","volume":"281","author":"RD Kouyos","year":"2014","unstructured":"Kouyos RD, Metcalf CJE, Birger R, Klein EY, Abel zur Wiesch P, Ankomah P, et al. The path of least resistance: aggressive or moderate treatment? Proc Biol Sci. 2014;281:20140566.","journal-title":"Proc Biol Sci"},{"key":"1090_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2047-2994-1-11","volume":"1","author":"J Carlet","year":"2012","unstructured":"Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D, et al. Ready for a world without antibiotics? The pensi\u00e8res antibiotic resistance call to action. Antimicrob Resist Infect Control. 2012;1:11.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1090_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkr137","volume":"66","author":"R Kaki","year":"2011","unstructured":"Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011;66:1223\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"1090_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis"},{"key":"1090_CR7","unstructured":"Antibiotic Resistance Threats in the United States. 2013. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/ ."},{"key":"1090_CR8","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.1073\/pnas.0402298101","volume":"101","author":"CT Bergstrom","year":"2004","unstructured":"Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA. 2004;101:13285\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1090_CR9","doi-asserted-by":"publisher","first-page":"e56040","DOI":"10.1371\/journal.pone.0056040","volume":"8","author":"CP Goulart","year":"2013","unstructured":"Goulart CP, Mahmudi M, Crona KA, Jacobs SD, Kallmann M, Hall BG, et al. Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes. PLoS One. 2013;8:e56040.","journal-title":"PLoS One"},{"key":"1090_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ng.1034","volume":"44","author":"E Toprak","year":"2012","unstructured":"Toprak E, Veres A, Michel J-B, Chait R, Hartl DL, Kishony R. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet. 2012;44:101\u20135.","journal-title":"Nat Genet"},{"key":"1090_CR11","doi-asserted-by":"publisher","first-page":"14494","DOI":"10.1073\/pnas.1409800111","volume":"111","author":"S Kim","year":"2014","unstructured":"Kim S, Lieberman TD, Kishony R. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci. 2014;111:14494\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1090_CR12","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","volume":"5","author":"L Imamovic","year":"2013","unstructured":"Imamovic L, Sommer MOA. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. 2013;5:204ra132.","journal-title":"Sci Transl Med"},{"key":"1090_CR13","doi-asserted-by":"publisher","first-page":"e1004225","DOI":"10.1371\/journal.ppat.1004225","volume":"10","author":"P AbelZurWiesch","year":"2014","unstructured":"AbelZurWiesch P, Kouyos R, Abel S, Viechtbauer W, Bonhoeffer S. Cycling empirical antibiotic therapy in hospitals: meta-analysis and models. PLoS Pathog. 2014;10:e1004225.","journal-title":"PLoS Pathog"},{"key":"1090_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1473-3099(08)70017-3","volume":"8","author":"S M\u00f6lstad","year":"2008","unstructured":"M\u00f6lstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125\u201332.","journal-title":"Lancet Infect Dis"},{"key":"1090_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1056\/NEJM199708143370701","volume":"337","author":"H Sepp\u00e4l\u00e4","year":"1997","unstructured":"Sepp\u00e4l\u00e4 H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441\u20136.","journal-title":"N Engl J Med"},{"key":"1090_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-139-6-200309160-00011","volume":"139","author":"M Sj\u00f6lund","year":"2003","unstructured":"Sj\u00f6lund M, Wreiber K, Andersson DI, Blaser MJ, Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med. 2003;139:483\u20137.","journal-title":"Ann Intern Med"},{"key":"1090_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1574-6976.2011.00289.x","volume":"35","author":"DI Andersson","year":"2011","unstructured":"Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev. 2011;35:901\u201311.","journal-title":"FEMS Microbiol Rev"},{"key":"1090_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"DI Andersson","year":"2010","unstructured":"Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8:260\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"1090_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jac\/dkp387","volume":"65","author":"M Sundqvist","year":"2010","unstructured":"Sundqvist M, Geli P, Andersson DI, Sj\u00f6lund-Karlsson M, Runehagen A, Cars H, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother. 2010;65:350\u201360.","journal-title":"J Antimicrob Chemother"},{"key":"1090_CR20","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1371\/journal.pcbi.0020137","volume":"2","author":"A Handel","year":"2006","unstructured":"Handel A, Regoes RR, Antia R. The role of compensatory mutations in the emergence of drug resistance. PLoS Comput Biol. 2006;2:e137.","journal-title":"PLoS Comput Biol"},{"key":"1090_CR21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/genetics\/154.3.985","volume":"154","author":"BR Levin","year":"2000","unstructured":"Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics. 2000;154:985\u201397.","journal-title":"Genetics"},{"key":"1090_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF00137351","volume":"3","author":"SJ Gould","year":"1970","unstructured":"Gould SJ. Dollo on Dollo\u2019s law: irreversibility and the status of evolutionary laws. J Hist Biol. 1970;3:189\u2013212.","journal-title":"J Hist Biol"},{"key":"1090_CR23","first-page":"496","volume-title":"The blind watchmaker: why the evidence of evolution reveals a universe without design","author":"R Dawkins","year":"1996","unstructured":"Dawkins R. The blind watchmaker: why the evidence of evolution reveals a universe without design. New York: WW. Norton & Company; 1996. p 496"},{"key":"1090_CR24","doi-asserted-by":"publisher","first-page":"198102","DOI":"10.1103\/PhysRevLett.106.198102","volume":"106","author":"L Tan","year":"2011","unstructured":"Tan L, Serene S, Chao HX, Gore J. Hidden randomness between fitness landscapes limits reverse evolution. Phys Rev Lett. 2011;106:198102.","journal-title":"Phys Rev Lett"},{"key":"1090_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature08249","volume":"461","author":"K Choowongkomon","year":"2009","unstructured":"Choowongkomon K, Ortlund EA, Thornton JW. An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature. 2009;461:515\u20139.","journal-title":"Nature"},{"key":"1090_CR26","unstructured":"WHO. World Malaria Report 2014. Geneva, World Health Organization, 2014. http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2014\/en\/ ."},{"key":"1090_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.1123539","volume":"312","author":"DM Weinreich","year":"2006","unstructured":"Weinreich DM, Delaney NF, Depristo MA, Hartl DL. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science. 2006;312:111\u20134.","journal-title":"Science"},{"key":"1090_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature05451","volume":"445","author":"FJ Poelwijk","year":"2007","unstructured":"Poelwijk FJ, Kiviet DJ, Weinreich DM, Tans SJ. Empirical fitness landscapes reveal accessible evolutionary paths. Nature. 2007;445:383\u20136.","journal-title":"Nature"},{"key":"1090_CR29","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.1073\/pnas.0905922106","volume":"106","author":"ER Lozovsky","year":"2009","unstructured":"Lozovsky ER, Chookajorn T, Brown KM, Imwong M, Shaw PJ, Kamchonwongpaisan S, et al. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci USA. 2009;106:12025\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1090_CR30","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1093\/molbev\/msq160","volume":"27","author":"KM Brown","year":"2010","unstructured":"Brown KM, Costanzo MS, Xu W, Roy S, Lozovsky ER, Hartl DL. Compensatory mutations restore fitness during the evolution of dihydrofolate reductase. Mol Biol Evol. 2010;27:2682\u201390.","journal-title":"Mol Biol Evol"},{"key":"1090_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12041-011-0072-z","volume":"90","author":"MS Costanzo","year":"2011","unstructured":"Costanzo MS, Hartl DL. The evolutionary landscape of antifolate resistance in Plasmodium falciparum. J Genet. 2011;90:187\u201390.","journal-title":"J Genet"},{"key":"1090_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00239-013-9582-z","volume":"77","author":"P-P Jiang","year":"2013","unstructured":"Jiang P-P, Corbett-Detig RB, Hartl DL, Lozovsky ER. Accessible mutational trajectories for the evolution of pyrimethamine resistance in the malaria parasite Plasmodium vivax. J Mol Evol. 2013;77:81\u201391.","journal-title":"J Mol Evol"},{"key":"1090_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0166-6851(97)00247-8","volume":"92","author":"PE de P\u00e9coulas","year":"1998","unstructured":"de P\u00e9coulas PE, Tahar R, Ouatas T, Mazabraud A, Basco LK. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol. 1998;92:265\u201373.","journal-title":"Mol Biochem Parasitol"},{"key":"1090_CR34","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4269\/ajtmh.2010.10-0259","volume":"83","author":"M Miao","year":"2010","unstructured":"Miao M, Yang Z, Cui L, Ahlum J, Huang Y, Cui L. Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China. Am J Trop Med Hyg. 2010;83:1206\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR35","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/AAC.45.11.3122-3127.2001","volume":"45","author":"M Imwong","year":"2001","unstructured":"Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, et al. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother. 2001;45:3122\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1090_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/dkr464","volume":"67","author":"K Mint Lekweiry","year":"2012","unstructured":"Mint Lekweiry K, Ould Mohamed Salem Boukhary A, Gaillard T, Wurtz N, Bogreau H, Hafid JE, et al. Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother. 2012;67:367\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"1090_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.meegid.2011.10.003","volume":"12","author":"M Afsharpad","year":"2012","unstructured":"Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND. Molecular assessment of dhfr\/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine\/pyrimethamine in combination with artesunate in Iran. Infect Genet Evol. 2012;12:38\u201344.","journal-title":"Infect Genet Evol"},{"key":"1090_CR38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4269\/ajtmh.2009.81.525","volume":"81","author":"L Khatoon","year":"2009","unstructured":"Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. Am J Trop Med Hyg. 2009;81:525\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4269\/ajtmh.2009.81.19","volume":"81","author":"C Barnadas","year":"2009","unstructured":"Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, et al. High prevalence and fixation of Plasmodium vivax dhfr\/dhps mutations related to sulfadoxine\/pyrimethamine resistance in French Guiana. Am J Trop Med Hyg. 2009;81:19\u201322.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4269\/ajtmh.2010.10-0004","volume":"83","author":"F Lu","year":"2010","unstructured":"Lu F, Lim CS, Nam DH, Kim K, Lin K, Kim T-S, et al. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. Am J Trop Med Hyg. 2010;83:474\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1475-2875-5-54","volume":"5","author":"M Schunk","year":"2006","unstructured":"Schunk M, Kumma WP, Miranda IB, Osman ME, Roewer S, Alano A, et al. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Malar J. 2006;5:54.","journal-title":"Malar J"},{"key":"1090_CR42","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1128\/AAC.00578-08","volume":"52","author":"C Barnadas","year":"2008","unstructured":"Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, et al. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother. 2008;52:4233\u201340.","journal-title":"Antimicrob Agents Chemother"},{"key":"1090_CR43","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1128\/AAC.48.7.2581-2587.2004","volume":"48","author":"S Brega","year":"2004","unstructured":"Brega S, de Monbrison F, Severini C, Udomsangpetch R, Sutanto I, Ruckert P, et al. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob Agents Chemother. 2004;48:2581\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1090_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.trstmh.2005.11.012","volume":"100","author":"N Valecha","year":"2006","unstructured":"Valecha N, Joshi H, Eapen A, Ravinderan J, Kumar A, Prajapati SK, et al. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg. 2006;100:831\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1090_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drup.2005.03.003","volume":"8","author":"IM Hastings","year":"2005","unstructured":"Hastings IM, Donnelly MJ. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2005;8:43\u201350.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"1090_CR46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.2006.75.617","volume":"75","author":"A Auliff","year":"2006","unstructured":"Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Le Ngoc A, et al. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg. 2006;75:617\u201321.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR47","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pgen.0030047","volume":"3","author":"B Peng","year":"2007","unstructured":"Peng B, Amos CI, Kimmel M. Forward-time simulations of human populations with complex diseases. PLoS Genet. 2007;3:e47.","journal-title":"PLoS Genet"},{"key":"1090_CR48","first-page":"87","volume":"57","author":"B Lipka","year":"2011","unstructured":"Lipka B, Milewska-Bobula B, Filipek M. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection\u2014own observations. Wiad Parazytol. 2011;57:87\u201392.","journal-title":"Wiad Parazytol"},{"key":"1090_CR49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4269\/ajtmh.2005.72.267","volume":"72","author":"FK Dzinjalamala","year":"2005","unstructured":"Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, et al. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 2005;72:267\u201372.","journal-title":"Am J Trop Med Hyg"},{"key":"1090_CR50","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1128\/AAC.49.9.3601-3606.2005","volume":"49","author":"FK Dzinjalamala","year":"2005","unstructured":"Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, et al. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrob Agents Chemother. 2005;49:3601\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1090_CR51","first-page":"268","volume":"41","author":"A Jamaludin","year":"1990","unstructured":"Jamaludin A, Mohamad M, Navaratnam V, Yeoh PY, Wernsdorfer WH. Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100\u00a0mg proguanil hydrochloride. Trop Med Parasitol. 1990;41:268\u201372.","journal-title":"Trop Med Parasitol"},{"key":"1090_CR52","first-page":"115","volume":"60","author":"E Weidekamm","year":"1982","unstructured":"Weidekamm E, Plozza-Nottebrock H, Forgo I, Dubach UC. Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmaco-kinetic data by computerized curve fitting. Bull World Health Organ. 1982;60:115\u201322.","journal-title":"Bull World Health Organ"},{"key":"1090_CR53","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.gde.2013.10.007","volume":"23","author":"DM Weinreich","year":"2013","unstructured":"Weinreich DM, Lan Y, Wylie CS, Heckendorn RB. Should evolutionary geneticists worry about higher-order epistasis? Curr Opin Genet Dev. 2013;23:700\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"1090_CR54","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/ng.2373","volume":"44","author":"DE Neafsey","year":"2012","unstructured":"Neafsey DE, Galinsky K, Jiang RHY, Young L, Sykes SM, Saif S, et al. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet. 2012;44:1046\u201350.","journal-title":"Nat Genet"},{"key":"1090_CR55","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, Mukadam RAG, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870\u20135.","journal-title":"J Infect Dis"},{"key":"1090_CR56","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/mmi.12162","volume":"88","author":"A Heinberg","year":"2013","unstructured":"Heinberg A, Siu E, Stern C, Lawrence EA, Ferdig MT, Deitsch KW, et al. Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum. Mol Microbiol. 2013;88:702\u201312.","journal-title":"Mol Microbiol"},{"key":"1090_CR57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1475-2875-13-150","volume":"13","author":"K K\u00fcmpornsin","year":"2014","unstructured":"K\u00fcmpornsin K, Kotanan N, Chobson P, Kochakarn T, Jirawatcharadech P, Jaru-ampornpan P, et al. Biochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase I. Malar J. 2014;13:150.","journal-title":"Malar J"},{"key":"1090_CR58","doi-asserted-by":"publisher","first-page":"11672","DOI":"10.1073\/pnas.1507142112","volume":"112","author":"S Pelleau","year":"2015","unstructured":"Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci USA. 2015;112:11672\u20137.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-016-1090-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1090-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:04:05Z","timestamp":1654167845000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1090-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1090-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"assertion":[{"value":"12 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"40"}}